SlideShare a Scribd company logo
HARAMAYA UNIVERSITY HIWOT
FANA COMPREHENSIVE SPECIALIZED
HOSPITAL
CLINICAL PHARMACY AND DRUG
AND POISON INFORMATION
SERVICE (DPIS) UNIT
BY SALAHADIN A. (B.PHARM)
1
Types of drug information resources
Literatures
2
At the end of this session the student will be able to:
• Identify different types of literatures with example
• Discuss advantages and disadvantages of literatures
• Criteria for evaluating drug information from internet
3
Three types of drug information literatures
Tertiary
literature
Secondary literature
Primary literature
4
A. Primary Literature
• Primary literature forms the foundation of the literature
hierarchy.
• It is the source of information for the development of
secondary and tertiary literature resources.
• Primary literature is comprised of original research that is
written in the author(s) own words.
• It consists of research studies, case reports, editorials,
and letters to the editor.
• Most primary literature contains a detailed description of
the study design, methodology, and scientific result
5
• Examples of excellent primary literature resources
include research articles and studies published in the
– New England Journal of Medicine
– Journal of the American Medical Association
– Archives of Internal Medicine
– Annals of Internal Medicine
– Lancet
– British Medical Journal
6
Advantages of primary literature:
• Information from primary literature is current,
original
• Many articles undergo review by the author's peers
before an article is accepted for publication,
thereby incorporating unbiased views and
suggestions to improve the quality of the
report(peer-review process)
7
Disadvantages of primary literature:
• With any research report, flaws in study
methodology may lead to inaccurate conclusions.
• In assessing the primary literature, knowledge of
scientific methods and statistics is necessary to
properly interpret the information.
• Since the information presented in the primary
literature is so new, it may take time before wide
acceptance occurs throughout the medical
community.
8
Using the primary literature
• Be cautious, careful, and conservative when utilizing
new information from a primary literature source.
• Articles published in peer-reviewed journals are
generally better in quality and objectivity than non-
peer reviewed work.
• In utilizing data from primary sources be sure that all
aspects of the primary source are understood
9
• To extrapolate primary literature data to a single
patient encounter, make sure the patient population
mentioned or utilized in the primary work
corresponds to your practice population.
• Remember that case reports relate only to one
patient not a whole patient population.
10
Using the primary literature…
B. Secondary Literature
• The secondary literature is compiled by indexing and
abstracting services that can be used to systematically
locate various types of published literature.
• Indexing consists of providing bibliographic citation
information (e.g., title, author, and citation of the
article),
• Abstracting also includes a brief description (abstract) of
the information provided by the article or resource cited.
• Examples : PubMed (Medline), Embase, National Library
of Medicine Gateway, International Pharmacy Abstracts,
Scopus, and Toxline, etc.
11
Abstracting service
12
Indexing service
13
Using the secondary literature
• Each database has its own focus, or scope, and collects
primary literature in a certain field about a disease, drug-
information, or literature related to patient care.
• Example: Medline focuses on the biomedical sciences,
Toxline focuses on toxicology,etc
• The databases link you to citations that show you the
author, title of the work, location and date of the
publication and generally, an abstract of the manuscript.
• Sometimes the full text of the article will be available, but
other times you need to get access to the article itself
through a subscription.
14
Advantages of secondary literature:
• Provides quick access to the primary literature.
• Provides a broad scope and/or concise information
on specific topics. The information is usually current,
but it depends on the abstracting service
• Generally, the journal sources are peer reviewed and
of a high standard.
15
Disadvantages of secondary literature:
• The time period between publication and inclusion (lag
time) into secondary sources can vary for each
database, from days to weeks.
• The number of journals indexed by each system
depends upon the scope of the database
• To obtain useful information, one must utilize specific
search terms and be proficient with a particular
database's search techniques.
16
C. Tertiary Literature
• The information presented in tertiary literature is core
knowledge established via primary literature or accepted
as standard of practice within the medical community.
• Drug information contained in the tertiary literature is
generally well-established information
• Tertiary references may be of textbooks on various drug
or disease topics (e.g. Pharmacotherapy), compendia (a
vast array of information about many drugs such as the
Physician's Desk Reference)
• As with any tertiary reference, the information should be
evaluated for bias.
17
18
Advantages of tertiary literature:
• Tertiary references are convenient and accessible
• Drug information references may be divided into
specific subjects to make them easier to use.
• For instance, one text may be devoted only to drug
interactions, while another might discuss principles
of pharmacotherapy or use of drugs in pregnancy.
• Usually the information contained in tertiary
literature is well accepted in medical practice.
19
Disadvantages of tertiary literature:
• Because of the lag time between when a text was
written and the actual publication date whether in
print or electronically, time passes before the
information is available, and more updated
information may be available in a database.
• Space limitations within a text may prevent extensive
discussion of a drug or topic.
• Authors may present information that is based on a
less than thorough review of the primary literature.
20
• The tertiary literature may not be referenced
appropriately.
• If the information presented in the tertiary literature
may based on flawed primary care literature
• updated or new information may need to be inserted
into the printed copy of the tertiary literature in a
timely fashion. This is time consuming, and may not
get accomplished
21
Evaluation of Tertiary Literature
• The reader should assess the text for timeliness
• The reader should assess consistency by comparing
information presented in one text to the same
information presented in another text.
• The reader should evaluate the credentials of the
authors/contributors.
• The reader should check the resource’s references,
and whether they are up-to-date.
22
23
3.2 Drug Information on the Internet
• The number of patients using the Internet for drug
information is on the rise.
• However, much of the information on the Internet
is unregulated; therefore, prudence is a necessity
prior to making decisions based on this
information.
• Very important thing to consider when using any
information resource for drug and medicine
information on the internet is ……to analyze
whether the information source is convincing,
reliable, up-to-date, and unbiased.
24
Responsibilities of Health care providers
• They should be competent in directing patients on
Internet usage
• Should be familiar with the vast array of professional-
based practice-enhancing resources available online.
• Should be able to provide guidance on how to
evaluate them.
• The key is to effectively sort through all of the
available information retrieved and quickly locate
reputable sources.
25
When is it most appropriate to use the Internet
source for drug information ?
• When company specific information is necessary, such as
information on pharmaceutical companies, Internet
information is usually readily available.
• Items in the news and current event topics are rapidly
available through the Internet.
• FDA, CDC, WHO is widely and freely available on the
Internet.
• Some information, such as rare diseases, alternative
medicine information.
26
What problems might be experienced in using
the Internet for drug and medicine
information?
• Accessing and navigating the Internet can be time
consuming and restraining.
• Not all content distributed over the Internet is useful.
• Many useful sites may charge a fee, or require a
subscription to get the information.
• Some sites require registration to access the use
content
27
28
Evaluating drug information from the Internet
1) Who manages this information?
• The person or group that has published health information
online should be identified
• Are the author’s credentials, such as years of experience,
position or education given?
• Is there contact information, such as an email address?
2) Purpose
• Who is paying for the project, and what is their purpose?
You should be able to find this information in the “About Us”
section.
• Who is the intended audience? Scholarly audience or
experts? General public or novices?
• Is the purpose of the site to inform, teach, persuade, or sell a
product?
29
The source of funding may be apparent in the suffix of
the Web site address.
– For example, addresses ending in ".gov" are
government-sponsored;
– Ending in ".edu" are sponsored by educational
institutions;
– Those ending in ".org" represent noncommercial
organizations;
– Web site addresses ending in ".com" identify
commercial organizations.
30
31
• The top three preferred sources of health
information by both patients and health care
professionals are;
– university/academic–based web sites,
– consumer Web sites sponsored by medical journals or
publications,
– government agency Web sites.
• Pharmaceutical manufacturer web sites are the least
preferred, followed by media-driven and commercial
medical organization–driven consumer sites
32
3) Reliability and Credibility
• Why should anyone believe information from this
site?
• Does the information appear to be valid, well-
researched, and supported by strong scientific
evidence?
• Is there a non-Web equivalent of this material that
would provide a way of verifying it is legitimate?
33
4) Currency
• If timeliness of the information is important, is it kept
up-to-date?
• Is there an indication of when the site was last
updated?
5) inks
• Are links related to the topic and useful to the
purpose of the site?
34
Some of Open-Access Drug Information Sources
Available Via the Internet
Web address Sponsor Area covered
www.clinicaitnals.gov National Institutes of
Health
Clinical trial registry
www.ashp.org
www.accp.com
www.amcp.org
American Society of Health
System
Pharmacists
Amercan College of Clinical
Pharmacy
Academy of managed Care
Pharmacy
Pharmacy practice
resources
www.pharmacist.com American Pharmacists
Association
Pharmacy practice
resources
www.emedicine.com Mescape General medicine
www.who.org WHO Guidelines and general
medicine
35
Web address Sponsor Area covered
www.merck.com Merck General medicine
www.nccam.nih.gov National Centers for
Complementary and
Alternative Medicine
Herbal and Alternative
Medicine
www.nlm.nih.gov/medline
plus
NIH medicine plus Patient information
www.cochrane.org Cochrane collaboration Evidence based medicine
www.nlm.nih.gov National library of medicine General health and
education: links to
MedlinePlus, AiDSinfo.
PubMed, and others
www.cdc.gov Centers for Disease Control
and Prevention
General health and
education
www.fda.gov Food and Drug
Administration
General information on
drugs and biologics 36
Reference
• C. R. Kothari, Research Methodology, Methods
and Techniques, 2nd Revised Edition, 2004.
37
THANK YOU
38

More Related Content

Similar to LITERATURE EVALUATION.pptx

Sonal evidence based orthodontics
Sonal evidence based orthodonticsSonal evidence based orthodontics
Sonal evidence based orthodontics
SahasrabudheSonal
 
Slide_Drug information_PharmD Khuê
Slide_Drug information_PharmD KhuêSlide_Drug information_PharmD Khuê
Slide_Drug information_PharmD Khuê
HA VO THI
 
Chapter 23
Chapter 23Chapter 23
Chapter 23bodo-con
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
Ramesh Ganpisetti
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdf
Ameena Kadar
 
role of pharmacist in poison center lab.pptx
role of pharmacist in poison center lab.pptxrole of pharmacist in poison center lab.pptx
role of pharmacist in poison center lab.pptx
hodafathysherif
 
Drug information system.pptx
Drug information system.pptxDrug information system.pptx
Drug information system.pptx
Gopalpokhrel8
 
Drug information Services.pptx
Drug information Services.pptxDrug information Services.pptx
Drug information Services.pptx
Dr.Navaneethakrishnan S
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformaticsaldebaran4
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformaticsaldebaran4
 
DRUG INFORMATION SYSTEM.pptx
DRUG INFORMATION SYSTEM.pptxDRUG INFORMATION SYSTEM.pptx
DRUG INFORMATION SYSTEM.pptx
Sangam Kanthale
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
Sumit Kumar
 
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
Ramesh Ganpisetti
 
Evidence based nursing resources
Evidence based nursing resourcesEvidence based nursing resources
Evidence based nursing resourcesDonna Chow
 
SSC in Evidence Based Medicine - Internet resources
SSC in Evidence Based Medicine - Internet resources SSC in Evidence Based Medicine - Internet resources
SSC in Evidence Based Medicine - Internet resources PaulaFunnell
 
Chapter1
Chapter1Chapter1
Chapter1
Fahad Sheref
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
4. review of literature
4. review of literature4. review of literature
4. review of literature
Chanda Jabeen
 
Online Medical Resources
Online Medical ResourcesOnline Medical Resources
Online Medical ResourcesTanveer Abbas
 

Similar to LITERATURE EVALUATION.pptx (20)

Sonal evidence based orthodontics
Sonal evidence based orthodonticsSonal evidence based orthodontics
Sonal evidence based orthodontics
 
Slide_Drug information_PharmD Khuê
Slide_Drug information_PharmD KhuêSlide_Drug information_PharmD Khuê
Slide_Drug information_PharmD Khuê
 
Drug information resources
Drug  information resourcesDrug  information resources
Drug information resources
 
Chapter 23
Chapter 23Chapter 23
Chapter 23
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdf
 
role of pharmacist in poison center lab.pptx
role of pharmacist in poison center lab.pptxrole of pharmacist in poison center lab.pptx
role of pharmacist in poison center lab.pptx
 
Drug information system.pptx
Drug information system.pptxDrug information system.pptx
Drug information system.pptx
 
Drug information Services.pptx
Drug information Services.pptxDrug information Services.pptx
Drug information Services.pptx
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformatics
 
3. application of pharmacoinformatics
3. application of pharmacoinformatics3. application of pharmacoinformatics
3. application of pharmacoinformatics
 
DRUG INFORMATION SYSTEM.pptx
DRUG INFORMATION SYSTEM.pptxDRUG INFORMATION SYSTEM.pptx
DRUG INFORMATION SYSTEM.pptx
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
 
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
 
Evidence based nursing resources
Evidence based nursing resourcesEvidence based nursing resources
Evidence based nursing resources
 
SSC in Evidence Based Medicine - Internet resources
SSC in Evidence Based Medicine - Internet resources SSC in Evidence Based Medicine - Internet resources
SSC in Evidence Based Medicine - Internet resources
 
Chapter1
Chapter1Chapter1
Chapter1
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
4. review of literature
4. review of literature4. review of literature
4. review of literature
 
Online Medical Resources
Online Medical ResourcesOnline Medical Resources
Online Medical Resources
 

More from Haramaya University

PHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.pptPHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.ppt
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
Haramaya University
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
Haramaya University
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
Haramaya University
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
Haramaya University
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
Haramaya University
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
Haramaya University
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
Haramaya University
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
Haramaya University
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
Haramaya University
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
Haramaya University
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
Haramaya University
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdfTirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Haramaya University
 
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdfRenal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Haramaya University
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
Haramaya University
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
Haramaya University
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
Haramaya University
 

More from Haramaya University (20)

PHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.pptPHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.ppt
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdfTirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
 
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdfRenal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
 

Recently uploaded

Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
preciousstephanie75
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
ranishasharma67
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 

Recently uploaded (20)

Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
 
10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience10 Ideas for Enhancing Your Meeting Experience
10 Ideas for Enhancing Your Meeting Experience
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 

LITERATURE EVALUATION.pptx

  • 1. HARAMAYA UNIVERSITY HIWOT FANA COMPREHENSIVE SPECIALIZED HOSPITAL CLINICAL PHARMACY AND DRUG AND POISON INFORMATION SERVICE (DPIS) UNIT BY SALAHADIN A. (B.PHARM) 1
  • 2. Types of drug information resources Literatures 2
  • 3. At the end of this session the student will be able to: • Identify different types of literatures with example • Discuss advantages and disadvantages of literatures • Criteria for evaluating drug information from internet 3
  • 4. Three types of drug information literatures Tertiary literature Secondary literature Primary literature 4
  • 5. A. Primary Literature • Primary literature forms the foundation of the literature hierarchy. • It is the source of information for the development of secondary and tertiary literature resources. • Primary literature is comprised of original research that is written in the author(s) own words. • It consists of research studies, case reports, editorials, and letters to the editor. • Most primary literature contains a detailed description of the study design, methodology, and scientific result 5
  • 6. • Examples of excellent primary literature resources include research articles and studies published in the – New England Journal of Medicine – Journal of the American Medical Association – Archives of Internal Medicine – Annals of Internal Medicine – Lancet – British Medical Journal 6
  • 7. Advantages of primary literature: • Information from primary literature is current, original • Many articles undergo review by the author's peers before an article is accepted for publication, thereby incorporating unbiased views and suggestions to improve the quality of the report(peer-review process) 7
  • 8. Disadvantages of primary literature: • With any research report, flaws in study methodology may lead to inaccurate conclusions. • In assessing the primary literature, knowledge of scientific methods and statistics is necessary to properly interpret the information. • Since the information presented in the primary literature is so new, it may take time before wide acceptance occurs throughout the medical community. 8
  • 9. Using the primary literature • Be cautious, careful, and conservative when utilizing new information from a primary literature source. • Articles published in peer-reviewed journals are generally better in quality and objectivity than non- peer reviewed work. • In utilizing data from primary sources be sure that all aspects of the primary source are understood 9
  • 10. • To extrapolate primary literature data to a single patient encounter, make sure the patient population mentioned or utilized in the primary work corresponds to your practice population. • Remember that case reports relate only to one patient not a whole patient population. 10 Using the primary literature…
  • 11. B. Secondary Literature • The secondary literature is compiled by indexing and abstracting services that can be used to systematically locate various types of published literature. • Indexing consists of providing bibliographic citation information (e.g., title, author, and citation of the article), • Abstracting also includes a brief description (abstract) of the information provided by the article or resource cited. • Examples : PubMed (Medline), Embase, National Library of Medicine Gateway, International Pharmacy Abstracts, Scopus, and Toxline, etc. 11
  • 14. Using the secondary literature • Each database has its own focus, or scope, and collects primary literature in a certain field about a disease, drug- information, or literature related to patient care. • Example: Medline focuses on the biomedical sciences, Toxline focuses on toxicology,etc • The databases link you to citations that show you the author, title of the work, location and date of the publication and generally, an abstract of the manuscript. • Sometimes the full text of the article will be available, but other times you need to get access to the article itself through a subscription. 14
  • 15. Advantages of secondary literature: • Provides quick access to the primary literature. • Provides a broad scope and/or concise information on specific topics. The information is usually current, but it depends on the abstracting service • Generally, the journal sources are peer reviewed and of a high standard. 15
  • 16. Disadvantages of secondary literature: • The time period between publication and inclusion (lag time) into secondary sources can vary for each database, from days to weeks. • The number of journals indexed by each system depends upon the scope of the database • To obtain useful information, one must utilize specific search terms and be proficient with a particular database's search techniques. 16
  • 17. C. Tertiary Literature • The information presented in tertiary literature is core knowledge established via primary literature or accepted as standard of practice within the medical community. • Drug information contained in the tertiary literature is generally well-established information • Tertiary references may be of textbooks on various drug or disease topics (e.g. Pharmacotherapy), compendia (a vast array of information about many drugs such as the Physician's Desk Reference) • As with any tertiary reference, the information should be evaluated for bias. 17
  • 18. 18
  • 19. Advantages of tertiary literature: • Tertiary references are convenient and accessible • Drug information references may be divided into specific subjects to make them easier to use. • For instance, one text may be devoted only to drug interactions, while another might discuss principles of pharmacotherapy or use of drugs in pregnancy. • Usually the information contained in tertiary literature is well accepted in medical practice. 19
  • 20. Disadvantages of tertiary literature: • Because of the lag time between when a text was written and the actual publication date whether in print or electronically, time passes before the information is available, and more updated information may be available in a database. • Space limitations within a text may prevent extensive discussion of a drug or topic. • Authors may present information that is based on a less than thorough review of the primary literature. 20
  • 21. • The tertiary literature may not be referenced appropriately. • If the information presented in the tertiary literature may based on flawed primary care literature • updated or new information may need to be inserted into the printed copy of the tertiary literature in a timely fashion. This is time consuming, and may not get accomplished 21
  • 22. Evaluation of Tertiary Literature • The reader should assess the text for timeliness • The reader should assess consistency by comparing information presented in one text to the same information presented in another text. • The reader should evaluate the credentials of the authors/contributors. • The reader should check the resource’s references, and whether they are up-to-date. 22
  • 23. 23 3.2 Drug Information on the Internet
  • 24. • The number of patients using the Internet for drug information is on the rise. • However, much of the information on the Internet is unregulated; therefore, prudence is a necessity prior to making decisions based on this information. • Very important thing to consider when using any information resource for drug and medicine information on the internet is ……to analyze whether the information source is convincing, reliable, up-to-date, and unbiased. 24
  • 25. Responsibilities of Health care providers • They should be competent in directing patients on Internet usage • Should be familiar with the vast array of professional- based practice-enhancing resources available online. • Should be able to provide guidance on how to evaluate them. • The key is to effectively sort through all of the available information retrieved and quickly locate reputable sources. 25
  • 26. When is it most appropriate to use the Internet source for drug information ? • When company specific information is necessary, such as information on pharmaceutical companies, Internet information is usually readily available. • Items in the news and current event topics are rapidly available through the Internet. • FDA, CDC, WHO is widely and freely available on the Internet. • Some information, such as rare diseases, alternative medicine information. 26
  • 27. What problems might be experienced in using the Internet for drug and medicine information? • Accessing and navigating the Internet can be time consuming and restraining. • Not all content distributed over the Internet is useful. • Many useful sites may charge a fee, or require a subscription to get the information. • Some sites require registration to access the use content 27
  • 28. 28
  • 29. Evaluating drug information from the Internet 1) Who manages this information? • The person or group that has published health information online should be identified • Are the author’s credentials, such as years of experience, position or education given? • Is there contact information, such as an email address? 2) Purpose • Who is paying for the project, and what is their purpose? You should be able to find this information in the “About Us” section. • Who is the intended audience? Scholarly audience or experts? General public or novices? • Is the purpose of the site to inform, teach, persuade, or sell a product? 29
  • 30. The source of funding may be apparent in the suffix of the Web site address. – For example, addresses ending in ".gov" are government-sponsored; – Ending in ".edu" are sponsored by educational institutions; – Those ending in ".org" represent noncommercial organizations; – Web site addresses ending in ".com" identify commercial organizations. 30
  • 31. 31
  • 32. • The top three preferred sources of health information by both patients and health care professionals are; – university/academic–based web sites, – consumer Web sites sponsored by medical journals or publications, – government agency Web sites. • Pharmaceutical manufacturer web sites are the least preferred, followed by media-driven and commercial medical organization–driven consumer sites 32
  • 33. 3) Reliability and Credibility • Why should anyone believe information from this site? • Does the information appear to be valid, well- researched, and supported by strong scientific evidence? • Is there a non-Web equivalent of this material that would provide a way of verifying it is legitimate? 33
  • 34. 4) Currency • If timeliness of the information is important, is it kept up-to-date? • Is there an indication of when the site was last updated? 5) inks • Are links related to the topic and useful to the purpose of the site? 34
  • 35. Some of Open-Access Drug Information Sources Available Via the Internet Web address Sponsor Area covered www.clinicaitnals.gov National Institutes of Health Clinical trial registry www.ashp.org www.accp.com www.amcp.org American Society of Health System Pharmacists Amercan College of Clinical Pharmacy Academy of managed Care Pharmacy Pharmacy practice resources www.pharmacist.com American Pharmacists Association Pharmacy practice resources www.emedicine.com Mescape General medicine www.who.org WHO Guidelines and general medicine 35
  • 36. Web address Sponsor Area covered www.merck.com Merck General medicine www.nccam.nih.gov National Centers for Complementary and Alternative Medicine Herbal and Alternative Medicine www.nlm.nih.gov/medline plus NIH medicine plus Patient information www.cochrane.org Cochrane collaboration Evidence based medicine www.nlm.nih.gov National library of medicine General health and education: links to MedlinePlus, AiDSinfo. PubMed, and others www.cdc.gov Centers for Disease Control and Prevention General health and education www.fda.gov Food and Drug Administration General information on drugs and biologics 36
  • 37. Reference • C. R. Kothari, Research Methodology, Methods and Techniques, 2nd Revised Edition, 2004. 37

Editor's Notes

  1. The mnemonic POEMS (Patient Oriented Evidence that Matters) is often utilized to define this information and the journals in which it is contained. Core Clinical Journals contain information about patient-oriented, evidence-based medicine that may change or affect patient care.
  2. (i.e. patient inclusion or exclusion criteria, study methods and interventions, primary outcome being assessed, statistical and clinical relevance of the reported findings), before applying that information to your patient).
  3. There are many secondary literature databases and each has its own scope, look, feel, and features to make it easy for the user to search the database
  4. The databases link you to citations that show you the author, title of the work, location and date of the publication and generally, an abstract of the manuscript.
  5. Because a secondary source can encompass such a large amount of information, one must be proficient at sifting through the sources listed on a particular subject to find the exact information one is looking for.
  6. The Institute of Medicine (IOM) has stated, "The Internet is a bit like the Wild West: It has vast amounts of unregulated territory and no one in charge."
  7. Some of the information is advertising from pharmaceutical companies, some contains discussions of people in support groups. You must be willing to take the time to critically and judiciously review all the information that is presented.
  8. Although manufacturer Web sites are the least preferred according to the HON 2005 survey, they often provide useful information such as drug acquisition/reimbursement instructions, medical information contacts, and current prescribing information. - See more at: http://www.uspharmacist.com/content/d/feature/c/19130/#sthash.TItbXKOT.dpuf